Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Galaxy MedicareNSE:GML 19 Receivables Turnover is 3.08 as of Mar. 2026. GuruFocus rates NSE:GML with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Galaxy Medicare ranks better than 53.51% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Galaxy Medicare's Revenue for the
six
months ended in Mar. 2026 was ₹212.7 Mil. Galaxy Medicare's average Accounts Receivable for the
six
months ended in Mar. 2026 was ₹69.1 Mil.
Hence, Galaxy Medicare's Receivables Turnover for the
six
months ended in Mar. 2026 was 3.08.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Galaxy Medicare Receivables Turnover Related Terms
Galaxy Medicare Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Galaxy Medicare's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GML vs ISRG, BDX, MDLN: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Galaxy Medicare's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galaxy Medicare Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Galaxy Medicare's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Galaxy Medicare's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galaxy Medicare (NSE:GML) has a Receivables Turnover of 3.08 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Galaxy Medicare and its competitors. According to the industry distribution chart, Galaxy Medicare ranks #377 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 46.5%.
Is Galaxy Medicare's Receivables Turnover too high?
Galaxy Medicare's current Receivables Turnover is 3.08. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Galaxy Medicare's value of 3.08 is 44.1% below this industry median. Based on the distribution chart, Galaxy Medicare ranks #377 out of 811 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Galaxy Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Galaxy Medicare's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Galaxy Medicare ranks #377 out of 811 companies for Receivables Turnover. This puts Galaxy Medicare in the upper half of its industry. The industry median Receivables Turnover is 5.51. Galaxy Medicare's value of 3.08 is 44.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galaxy Medicare's current Receivables Turnover of 3.08 is 44.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Galaxy Medicare and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galaxy Medicare's current Receivables Turnover is 3.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galaxy Medicare stock overvalued right now?
Galaxy Medicare (NSE:GML) has a current Receivables Turnover of 3.08. The current Receivables Turnover is 3.08 and 44.1% below the Medical Devices & Instruments industry median of 5.51. Galaxy Medicare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Galaxy Medicare (NSE:GML), the current Receivables Turnover is 3.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Galaxy Medicare Ltd is engaged into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompass: Manufacturing and Branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC.
19GF Score
Get the complete analysis for NSE:GML
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GML has been successfully added to your 
